Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details

Brazilian Wood Claims Evaluated: Discover the Male Enhancement Hardening Pill Truth by SuperNatural Man

Kairos Power Breaks Ground on Hermes 2 Demonstration Plant

EducationDynamics Named Reddit Gold Sales Certified Partner, Giving Institutions an Edge in the Channels Students Trust Most

MOBI Home Clinic Enables Remote Health Monitoring Without Constant In-Person Visits

New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma

Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application

PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic...

Lakeland Industries, Inc. (LAKE) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting...

Nested Therapeutics Reports Initial Encouraging Clinical Activity and Favorable Tolerability of NST-628, a Brain-Penetrant Pan-RAF/MEK...

Pheast Therapeutics Reports Initial Phase 1a Data Showing Early Clinical Activity and Target Engagement for PHST001 at AACR 2026

Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune...

Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting...

Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting

Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug Conjugate Targeting Trop-2 and Nectin-4 at the...

Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for...

Crestwood Advisors Named Once Again to USA TODAY’s 2026 Best Financial Advisory Firms List

MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer

New ACP Breast Cancer Screening Guidelines Are a Step Backward that May Cost Lives